.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Express Scripts
Fuji
McKinsey
Cantor Fitzgerald
Julphar
Chubb
Daiichi Sankyo
Mallinckrodt
Cerilliant

Generated: November 21, 2017

DrugPatentWatch Database Preview

Ferring Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for FERRING PHARMS INC, and what generic alternatives to FERRING PHARMS INC drugs are available?

FERRING PHARMS INC has six approved drugs.

There are two US patents protecting FERRING PHARMS INC drugs.

There are twenty-three patent family members on FERRING PHARMS INC drugs in sixteen countries.

Summary for Ferring Pharms Inc

International Patents:23
US Patents:2
Tradenames:6
Ingredients:3
NDAs:6
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-001Mar 30, 1984APRXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
CERVIDIL
dinoprostone
INSERT, EXTENDED RELEASE;VAGINAL020411-001Mar 30, 1995RXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-002Apr 25, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
PREPOPIK
citric acid; magnesium oxide; sodium picosulfate
FOR SOLUTION;ORAL202535-001Jul 16, 2012RXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms Inc
STIMATE (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL020355-002Oct 24, 2007RXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
SPRAY, METERED;NASAL017922-002Feb 6, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL017922-003Aug 7, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-002Sep 6, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-001Sep 6, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
PREPOPIK
citric acid; magnesium oxide; sodium picosulfate
FOR SOLUTION;ORAL202535-001Jul 16, 2012RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ferring Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-001Mar 30, 1984► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL017922-003Aug 7, 1996► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL017922-003Aug 7, 1996► Subscribe► Subscribe
Ferring Pharms Inc
CERVIDIL
dinoprostone
INSERT, EXTENDED RELEASE;VAGINAL020411-001Mar 30, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-002Sep 6, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-001Sep 6, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
SOLUTION;NASAL017922-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
SOLUTION;NASAL017922-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-002Apr 25, 1995► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-001Sep 6, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for FERRING PHARMS INC drugs

Drugname Dosage Strength Tradename Submissiondate
sodium picosulfate, magnesium oxide and anhydrous citric acid
Oral Solution10 mg, 3.5 g, and 12 g
PREPOPIK
5/21/2014

International Patent Family for Ferring Pharms Inc Drugs

Country Document Number Estimated Expiration
BrazilPI0818541► Subscribe
Japan5654873► Subscribe
China101820859► Subscribe
South Korea20100072020► Subscribe
Taiwan200924759► Subscribe
World Intellectual Property Organization (WIPO)2009047633► Subscribe
Israel204500► Subscribe
Russian Federation2010112483► Subscribe
TaiwanI418352► Subscribe
South Africa201002131► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
QuintilesIMS
Novartis
Daiichi Sankyo
Fish and Richardson
McKinsey
Cipla
Argus Health
Harvard Business School
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot